Ohm: I just thought of another question, would app
Post# of 157604
Quote:
Ohm: I just thought of another question, would approval for MSS mCRC also allow use of LL in MSS CRC that was not yet metastatic?
The FDA could broaden usage depending on results from the trial, but usually they stick to whatever the trial parameters are.

